Precipio, Inc. (PRPO) Ilan Danieli, CEO The Wall Street Resource

Precipio is a healthcare biotechnology company
focused on cancer diagnostics. Our mission is to address the pervasive problem
of cancer misdiagnoses by developing solutions in the form of diagnostic
products and services. Our products and services deliver higher accuracy,
improved laboratory workflow, and ultimately better patient outcomes, which
reduce healthcare expenses. Precipio develops innovative technologies in our
laboratory where we design, test, validate, and use these products clinically,
improving diagnostic outcomes. Precipio then commercializes these technologies
as proprietary products that serve the global laboratory community and further
scales Precipio’s reach to eradicate misdiagnosis.